VON ESCHENBACH ANDREW C.

CIK 00015365297 companiesVAUGHAN

SEC Profile

Transactions

Companies

Filings

CIK

0001536529

Recent Transactions

35 trades

Award
Bausch & Lomb Corp$BLCO
Common Shares, No Par Value
2026-05-26$15.78/sh+15,842→ 86,656 total
Purchase
Bausch & Lomb Corp$BLCO
Common Shares, No Par Value
2026-02-27$18.30/sh+4,364→ 66,450 total
Award
Bausch & Lomb Corp$BLCO
Common Shares, No Par Value
2026-02-27+4,364→ 70,814 total
Award
Bausch & Lomb Corp$BLCO
Common Shares, No Par Value
2025-05-27+20,338→ 62,086 total
Purchase
Bausch & Lomb Corp$BLCO
Common Shares, No Par Value
2025-05-02$11.76/sh+1,695→ 41,748 total
Award
TriSalus Life Sciences, Inc.$TLSI
Director stock option (right to buy)
2024-08-13+15,000→ 15,000 total
Award
Bausch & Lomb Corp$BLCO
Common Shares, No Par Value
2024-08-02+14,696→ 40,053 total
Gift
TriSalus Life Sciences, Inc.$TLSI
Stock Option (right to buy)
2024-06-03−35,000→ 0 total
Gift
TriSalus Life Sciences, Inc.$TLSI
Stock Option (right to buy)
2024-06-03+35,000→ 35,000 total
Award
TriSalus Life Sciences, Inc.$TLSI
Stock Option (right to buy)
2023-08-10+35,000→ 35,000 total
Award
Celularity Inc$CELU
Class A Common Stock
2023-06-14+199,921→ 336,066 total
Award
Celularity Inc$CELU
Stock Option (Right to Buy)
2023-06-14+277,778→ 277,778 total
Award
Bausch & Lomb Corp$BLCO
Common Shares, No Par Value
2023-05-04+12,857→ 25,357 total
Disposition to Issuer
Radius Health, Inc.
Common Stock
2022-08-15$10.00/sh−5,500→ 0 total
Disposition to Issuer
Radius Health, Inc.
Stock Option (Right to Buy)
2022-08-15$3.60/sh−10,000→ 0 total
Award
Celularity Inc$CELU
Stock Option (Right to Buy)
2022-07-13+54,152→ 54,152 total
Award
Celularity Inc$CELU
Class A Common Stock
2022-07-13+36,145→ 136,145 total
Award
Bausch & Lomb Corp$BLCO
Common Shares, No Par Value
2022-05-10+12,500→ 12,500 total
Award
Radius Health, Inc.
Common Stock
2022-01-14+5,500→ 5,500 total
Award
Radius Health, Inc.
Stock Option (Right to Buy)
2022-01-14+10,000→ 10,000 total
Exercise/Conversion
Celularity Inc$CELU
Class A Common Stock
2021-11-09$0.28/sh+100,000→ 100,000 total
Exercise/Conversion
Celularity Inc$CELU
Stock Option (Right to Buy)
2021-11-09−100,000→ 207,437 total
Award
Celularity Inc$CELU
Stock Option (Right to Buy)
2021-09-09+56,053→ 56,053 total
Purchase
Bausch Health Companies Inc.$BHC
Common Shares, No Par Value
2021-08-05$25.94/sh+1,400→ 38,647 total
Award
Celularity Inc$CELU
Deferred Compensation Award (Right to Buy)
2021-07-16+269,007→ 269,007 total
Award
Celularity Inc$CELU
Stock Option (Right to Buy)
2021-07-16+307,437→ 307,437 total
Award
Bausch Health Companies Inc.$BHC
Common Shares, No Par Value
2021-04-30+7,645→ 37,247 total
Award
Radius Health, Inc.
Stock Option (Right to Buy)
2021-01-04+30,000→ 30,000 total
Award
Bausch Health Companies Inc.$BHC
Common Shares, No Par Value
2020-05-01+11,037→ 29,602 total
Purchase
Bausch Health Companies Inc.$BHC
Common Shares, No Par Value
2020-03-10$18.18/sh+1,100→ 18,565 total
Award
Bausch Health Companies Inc.$BHC
Common Shares, No Par Value
2019-05-03$23.51/sh+10,633→ 17,465 total
Award
Bausch Health Companies Inc.$BHC
Common Shares, No Par Value
2018-10-29+5,832→ 6,832 total
Purchase
Lineage Cell Therapeutics, Inc.$LCTX
Common Shares, no par value
2013-08-12$3.69/sh+3,000→ 3,000 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Option to Purchase Common Shares
2013-07-01+20,000→ 20,000 total
Award
Lineage Cell Therapeutics, Inc.$LCTX
Option to Purchase Common Shares
2012-07-01+20,000→ 20,000 total

Companies

Recent Filings

Address

C/O BAUSCH + LOMB CORPORATION 520 APPLEWOOD CRESCENT

VAUGHAN, L4K 4B4

View on SEC.gov